Sort
21,453 grants matching “tuberculosis”
The effect of HIV exposure and infection on immunity to TB in children
$774,910Grace C John-Stewart · University Of Washington · R01 · FY2022 · AI
Pro-apoptotic Drugs as Host-Directed Treatments for Pulmonary Tuberculosis
$774,881Sanjay Jain · Johns Hopkins University · R01 · FY2025 · AI
Spatio-temporal data integration methods for infectious disease surveillance
$774,780Justin V Remais · University Of California Berkeley · R01 · FY2017 · AI
Genes/Pathways for ATG Gene-dependent Inhibition of Viruses & Parasite Infection
$774,740Herbert W Virgin · Washington University · U19 · FY2014 · AI
Unraveling the intersection of substance use, inflammation, and HIV via hair levels
$774,688Monica Gandhi · University Of California, San Francisco · R01 · FY2023 · DA
Modeling Core
$774,605Nitin S Baliga · Seattle Biomedical Research Institute · U19 · FY2013 · AI
INDIANA STATE DEPT OF HEALTH TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE
$774,582Sarah Burkholder · Indiana State Department Of Health · U52 · FY2010 · PS
Discovery and validation of drug resistance mutations
$774,241Eric H. Rubin · Harvard Medical School · U19 · FY2015 · AI
HIV, gestational diabetes and TB in pregnancy
$773,903Jyoti S Mathad · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AI
Transmission of HIV-Associated XDR TB in Rural South Africa
$773,830Nippie Sarita Shah · Albert Einstein College Of Medicine · R01 · FY2011 · AI
Macaque Models of AIDS-Related Tuberculosis and T Cell
$773,825Zheng W Chen · University Of Illinois At Chicago · R01 · FY2007 · HL
Using Lipids for Vaccination
$773,720Luc Teyton · Scripps Research Institute, The · U01 · FY2010 · AI
Targeting TB transmission hotspots to find undiagnosed TB in South Africa: a genomic, geospatial and modeling study (TARGET- TB)
$773,637Barun Mathema · Columbia University Health Sciences · R01 · FY2021 · AI
Research Program and Administrative Center
$773,616Judith E.n. Albino · University Of Colorado Denver · U54 · FY2014 · DE
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit
$773,601Beatriz Grinsztejn · Fundacao Oswaldo Cruz · UM1 · FY2018 · AI
Novel delivery platform and antigen design for an effective COVID-19 vaccine
$773,534Suresh K Mittal · Purdue University · R01 · FY2021 · AI
Enhancing cytotoxic lymphocytes in a TB vaccine strategy
$773,531Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
The role of pathogen-experienced macrophage subsets in mediating lung immunity and heterologous protection
$773,368Amariliz Rivera · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI
Development of novel penems for drug-resistant tuberculosis
$773,080Craig A Townsend · Johns Hopkins University · R01 · FY2020 · AI
Characteristics and protective efficacy of human antibodies against M. tuberculosis
$773,048Jacqueline Michele Achkar · Albert Einstein College Of Medicine · R01 · FY2021 · AI
Preventing TB with intravenous BCG in SIV-infected macaques
$772,812Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI
Understanding early macrophage-T cell interactions, SLAMF1, and immunity to TB
$772,420Jennifer A Philips · Washington University · R01 · FY2024 · AI
Understanding early macrophage-T cell interactions, SLAMF1, and immunity to TB
$772,420Jennifer A Philips · Washington University · R01 · FY2025 · AI
TB Vaccine Development in Nonhuman Primate Model
$772,391John L Vandeberg · Texas Biomedical Research Institute · R01 · FY2006 · AI
Cohort Analytics Core
$772,313Joshua Denny · National Human Genome Research Institute · ZIC · FY2025 · HG